Navigating a complex regulatory landscape for IVDR

The In Vitro Device Regulation (IVDR) comes into force on 25 May 2022, which means companies must start complying with the regulations. While we’re seeing many companies have aspects in place, there are many issues that they may not have considered. For example, if you’re using a biomarker assay in your clinical study, has it […]